Dr. Andrew Lyon is the recipient of the Canadian Society of Clinical Chemists (CSCC) Award for Outstanding Contribution to Clinical Chemistry for 2026. This award for outstanding achievement in and/or contribution to the field of clinical chemistry recognizes the many achievements during Dr. Lyon’s career of over 35 years where he has demonstrated excellence as clinical biochemist, educator, leader, and scholar. He has left a positive and impactful mark on practically every aspect of the profession.

Known for his collegial approach, Dr. Lyon is described as a visionary clinical chemist who understands how to best serve patients and medical colleagues by fostering strong professional relationships. In leadership roles, Dr. Lyon has demonstrated exceptional administrative and strategic skills. He served as Division Head of Clinical Biochemistry at Calgary Laboratory Services from 2003 to 2008 followed by the same role in Saskatoon from 2012 to 2024. His ability to mentor and develop others has been critical to cultivate the next generation of clinical chemists and laboratory leaders.

His service to the profession has been extensive and sustained over the past decades. Dr. Lyon has been a Fellow of the Canadian Academy of Clinical Biochemistry (CACB) since 1994 and has held numerous leadership roles within the CACB, including Chair of the Certification Committee and member of the Board of Directors. He has also served the CSCC in multiple leadership and governance roles, including Councillor, Division Head of Educational Affairs, and most notably as CSCC President during 2015 to 2017. But what is little known among the most current members is that Dr. Lyon was instrumental in leading the very first iteration of the CSCC website.  The launch of the “www.cscc.ca” domain coincided with the 1997 CSCC annual meeting in Halifax.

Dr. Lyon has received numerous awards throughout his career including the CSCC Award for Research Excellence, Donald J. Campbell Award for Outstanding Contribution to Clinical Biochemistry from the Alberta Society of Clinical Chemists (ASCC), the CACB Outstanding Contribution to the Profession of Clinical Biochemistry, the Bayer Diagnostics Scholarship from the Clinical Laboratory Management Association (CLMA), and the AVL Scientific Award for Significant Advances in Critical Care Testing for Canada from the International Federation of Clinical Chemistry (IFCC).

Having held faculty positions in medical schools at the University of Saskatchewan and the University of Calgary, Dr. Lyon has made significant scholarly contributions, including 102 peer‑reviewed publications, more than 116 abstracts and conference proceedings, 7 book chapters, and numerous additional publications. His expertise is recognized nationally and internationally, evidenced by more than 30 invited talks. His research has been supported by major funding agencies such as Canadian Institutes of Health Research (CIHR) and the Alberta Heritage Foundation for Medical Research. He has also contributed widely to the scientific community through service on grant review panels and editorial boards for leading journals in clinical chemistry and laboratory medicine.

As an educator, Dr. Lyon has a vast depth of experience teaching undergraduate and graduate students, including the supervision or advisory of several master’s and PhD students. He is widely respected for his ability to explain complex biochemical and laboratory medicine concepts in a way that is accessible and meaningful to learners at all stages of training. His long-standing commitment to education is reflected not only in the classroom, but also through his extensive involvement in continuing medical education, conference planning activities, and professional societies.

The entire CSCC community recognizes the unwavering dedication of Dr. Lyon to the field of clinical chemistry and his tireless efforts to advance it. As colleagues, learners, and ultimately the patients and public, we have benefitted from Dr. Lyon’s leadership through significant and positive contributions to diverse areas through laboratory medicine.

1. Nominations for this Award shall be solicited annually in the Newsletter, website, and email of the Society.
2. The deadline for nominations is October 31, in the year before the Award is to be presented.
3. The Award shall be presented as a mark of recognition of outstanding achievement in and/or contribution to the field of clinical chemistry.
4. The Award shall usually be presented annually, but if in the opinion of the Nominations and Awards Committee no suitable candidate is available in any year, the Award shall not be made.
5. The Award shall be accompanied by a framed certificate and an honorarium in the amount of $1,500. The balance remaining after the honorarium shall be used to meet the administrative expenses, the production of the framed certificate, and to make a contribution towards expenses involved in ensuring the attendance of the recipient at the Annual Conference of the Society.
6. No formal nomination procedure is specified, but Members of the Society may propose suitable candidates to the Nominations and Awards Committee through the Head Office of the Society (info@cscc-sccc.ca). Curriculum vitae and any other suitable documentation in support of the nominee must accompany nominations from the membership.
7. The Nominations and Awards Committee shall select one of the nominees for the Award for recommendation to the Council of the Society at its Fall Council meeting in the year before the Award is to be presented. 
8. The President of the Society will notify the recipient of the Award and inform the sponsor of the name of the recipient of the Award not later than March 1 in the year in which the Award is to be presented.
9. The recipient of the Award is not usually expected to give an address or give a paper, but the Award and the reading of the citation shall usually be made at the Annual Conference of the Society. A representative of the sponsor shall be invited to participate in the presentation.
10. The amendment of these Terms of Reference is the responsibility of the Council, subject to the concurrence of the sponsor of the Award. Council of the Society and the corporate sponsor of this award should review these terms of reference a minimum of once every five (5) years.

The CSCC Award for Innovation in Laboratory Medicine is presented to a clinical laboratory in Canada that has distinguished itself by outstanding accomplishment through innovation in the field of clinical chemistry, pathology, or laboratory medicine. The 2026 recipient is Alberta Precision Laboratories (APL). The Clinical Chemist team innovated with a provincial testing program for hemoglobinopathies.

All requests for hemoglobinopathy investigations across the entire province of Alberta (including confirmation of positive newborn screens) now follow a standardized testing algorithm that includes initial screening by capillary electrophoresis, complete blood count and iron studies, followed by reflexive confirmatory testing with gel electrophoresis and/or molecular analysis. Interpretation of results has also been standardized through the development of a comprehensive procedure and canned comments that cover >95% of cases. The endeavor started in 2022 with initial roll out by the Edmonton team in the spring of 2023. After a period of training and handover to the Calgary team, the provincial data analysis and optimization of reflex thresholds was completed in 2025, reducing unnecessary analyses and saving valuable healthcare resources.

The province wide hemoglobinopathy testing program collaborated with the Departments of Hematopathology and Genetics and Genomics, as well as Hematologists across Alberta, to design, implement, and optimize the process. The innovative program had 3 important goals:

1. Transition hemoglobinopathy screening from the Hematopathology Department to the Chemistry Department by advocating for Clinical Chemistry oversight, acquiring and validating new instrumentation, and leading staff training.
2. Develop and implement a provincial program for hemoglobinopathy testing that encompasses both initial screening and confirmatory analysis, developing a comprehensive interpretive algorithm, and standardized reports.
3. Optimize reflexive thresholds for confirmatory testing by completing in-depth data analysis, engaging clinical stakeholders, and implementing evidence-based practice changes.

The team of Clinical Chemists at APL took the initiative to understand existing practices, design an improved provincial algorithm, and prepare the business case to consolidate testing provincially under Chemistry. At the laboratory level, the team validated new instruments, created standardized interpretive procedures, and trained staff across the province. For clinical engagement, they worked collaboratively with key stakeholders to design a provincial algorithm based on clinical needs and best practices, and conducted education for healthcare providers. After rollout, they analyzed provincial data to refine confirmatory testing criteria and guided stakeholders through updates and implementation. In one example, the optimized screening for alpha-thalassemia eliminated 350 unnecessary molecular tests/year thus saving valuable healthcare resources.

Implementation of a standardized provincial hemoglobinopathy program has resulted in consistency of both testing and reporting, no matter where in the province a sample is drawn. Development of a single comprehensive interpretative procedure has enhanced efficiency, decreased errors, and facilitated teaching the next generation of healthcare professionals. It has also ensured equal access to confirmatory testing for all Albertans, including expedited confirmation of positive newborn screening results for hemoglobinopathies. A cross-disciplinary approach that leverages the expertise of Clinical Chemists, Hematopathologists, and Molecular Geneticists has fostered continuous learning and new collaborations.

The program exemplifies that Clinical Chemists can play a central role in large-scale hemoglobinopathy testing, a responsibility traditionally led by hematopathologists. By working across disciplines, Clinical Chemists demonstrate value by managing screening interpretation and program optimization, while Molecular Geneticists and Hematopathologists handle molecular confirmations and additional testing. This teamwork ensures accurate diagnoses for complex cases. As a result of their efforts, a standardized, province‑wide approach to hemoglobinopathy testing was achieved. The success of Alberta Precision Labs’ model may encourage other jurisdictions to involve Clinical Chemistry more fully and adopt similar integrated, standardized testing frameworks.

The team now signs out most hemoglobinopathy cases in the province, raising the profile of Clinical Chemistry within the healthcare system. Their expertise has led to frequent consultations from hematologists, genetic counselors, and other clinicians, strengthening interdisciplinary relationships. The initiative has also enhanced the Chemistry Department’s academic presence at both the University of Alberta and the University of Calgary, where the team’s expertise has positioned them to provide hemoglobinopathy education to medical residents and fellows across Alberta, earning them consistently excellent evaluations.

Congratulations to Dr. Mathew Estey (Medical Lead Clinical Biochemistry, Hub Lab North), Kay Ng (Director, Hub Lab North), and the entire APL Clinical Chemist team for the success of their development of a new laboratory program.

1. Nominations for this Award shall be solicited annually in the Newsletter, website, and email of the Society.
2. The deadline for nominations is October 31, in the year before the Award is to be presented.
3. The Award shall be presented to a Clinical Laboratory in Canada that has distinguished itself by outstanding accomplishment through innovation in the field of Clinical Chemistry, or Pathology and Laboratory Medicine for projects where a CSCC member was directly involved. This award is intended to encourage and recognize excellence in Clinical Laboratory Services, especially in the role of improving the quality of health care, improving patient outcomes, and promoting a positive public image to clinical laboratories and laboratory professionals.
4. Eligible organizations for this Award include:
   1. Private, Academic and Government Clinical Laboratories and Laboratory divisions.
   2. Rural and Regional Clinical Laboratories and Clinical Laboratory Departments.
5. Laboratories demonstrating outstanding accomplishments in one or more of the following areas completed within the last two calendar years are eligible for consideration:
   1. Innovation in strategic planning and implementation of laboratory services based on best practices.
   2. Innovation in development of new laboratory programs (e.g. new tests, facilities, and changes in practice).
   3. Innovation in teaching and education.
   4. Promotion of a positive public image for laboratory medicine.
6. Members of the CSCC can nominate suitable candidates for this Award using the online application form on the CSCC Awards page of the CSCC website. Nominations for this award will include:
   1. A summary of the accomplishment(s) of the nominated organization with supporting documentation.
   2. A letter of support from a CSCC member involved in the project for which the organization is being nominated.
   3. A letter of support from the nominee’s organization administrative team (Signed by a Department Director, VP, or CEO).
7. Nominees having received this Award within the last 3 years will not be eligible to receive this Award for a current year.
8. The Award shall usually be presented annually, but if in the opinion of the Nominations and Awards Committee there is (are) no suitable candidate(s) available in any year, the Award shall not be made.
9. The Nominations and Awards Committee shall select one of the nominees for the Award for recommendation to the Council of the Society at its Fall Council meeting in the year before the Award is to be made.
10. The President of the Society will notify the recipient organization of the Award and inform the sponsor of the name of the recipient of the Award not later than March 1 in the year in which the Award is made.
11. The CSCC supporting member and a representative from the administration of hospital or institution represented in the project will be invited to accept the Award (display item) at the CSCC Annual Meeting. The Award will be presented by a representative of the sponsor. If applicable, the Award will cover airfare, accommodation and expenses for 2 nights for both recipients, as per the CSCC Travel Guidelines. The intent is for CSCC to support the primary applicant to attend. If there are co-lead(s), then the primary applicant is to determine if/how funds will be shared. The expectation is that the CSCC would support the applicant in finding an administrator (clinical or operational) to receive the award.
12. The recipient of the Award is not usually expected to give an address, but the Award and the reading of the citation shall usually be made at the Annual Conference of the Society. A representative of the sponsor shall be invited to participate in the presentation.
13. The amendment of these Terms of Reference is the responsibility of the Council, subject to the concurrence of the sponsor of the Council of the Society and the corporate sponsor of this award should review these Terms of Reference a minimum of once every five (5) years.

CSCC Award for Innovation in Laboratory Medicine – nomination form

Dr. Lei Fu is the recipient of the 2026 CSCC Award for Research Excellence. This award is presented to an individual or group for their contribution to research directly or indirectly related to clinical chemistry in Canada.

Dr. Fu has contributed significantly to the understanding of biomarkers in maternal-fetal health and clinical applications of pharmacogenetics. Her translational research work has enabled greater personalized medicine that has direct impact on the well-being of patients. Currently, she is clinical biochemist in the Precision Diagnostics and Therapeutics Program at Sunnybrook Health Sciences Centre and holds the position of Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto.

After her graduate studies, Dr. Fu completed postdoctoral research in pharmacology and molecular virology at the Yale University School of Medicine. This was followed by clinical chemistry training in the McMaster University fellowship program prior to joining Sunnybrook in 2002. In addition to her CACB certification, she is a Diplomate of the American Board of Clinical Chemistry in three disciplines: Clinical Chemistry, Toxicological Chemistry, and Molecular Diagnostics.

Dr. Fu has successfully secured funding from both local and international sources, facilitating her work in advancing applied medical research to enhance patient care. She has published and presented her work at provincial, national, and international levels, where several of her contributions have received outstanding research recognition from the Association for Diagnostics & Laboratory Medicine (ADLM). A notable achievement of Dr. Fu’s is her instrumental role in making Sunnybrook the first hospital in North America to implement innovative assays—soluble fms-like tyrosine kinase 1 (sFLT-1) and placental growth factor (PlGF)—for diagnosing preeclampsia in pregnant women. This advancement enables clinicians to provide more accurate diagnostics and was acknowledged through the 2024 CSCC Award for Innovation in Laboratory Medicine. Furthermore, Dr. Fu developed a multiplex AS-PCR assay to rapidly detect five variants in the DPYD gene, which is crucial for fluoropyrimidine metabolism. This assay can be used for screening DPYD variants to identify patients with increased risk of toxicity when prescribed fluoropyrimidine therapy.

In addition to her research achievements, Dr. Fu is dedicated to education, teaching both graduate and undergraduate courses. She has supervised over twenty research students, medical doctors, postdoctoral fellows, and medical laboratory technologists, fostering the next generation of professionals in the field.

Dr. Fu actively shares her expertise through many professional bodies at the international level including Clinical Pharmacogenetics Implementation Consortium (CPIC), Pharmacogene Variation Consortium (PharmVar), ADLM Academy, International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), and Clinical and Laboratory Standards Institute (CLSI).  More importantly, she is able to bring her knowledge home for the benefit of Canadians, particularly in Ontario where she serves on provincial bodies advising on pharmacogenomic and pharmacogenetic testing and also preeclampsia screening in the first trimester.

1. Nominations for this Award shall be solicited annually in the Newsletter, website, and email of the Society.
2. The deadline for nominations is October 31, in the year before the Award is to be presented.
3. The Award shall be presented to an individual or group as a mark of recognition of their contribution to research directly or indirectly related to clinical chemistry in Canada.
4. The Award shall usually be presented annually, but if in the opinion of the Nomination and Awards Committee no group or individual is available in any year, the Award shall not be made.
5. The Award shall be accompanied by a framed certificate and by an honorarium in the amount of $1,500. The balance remaining after the honorarium shall be used to meet the administrative expenses, the production of the framed certificate, and to make a contribution towards expenses involved in ensuring the attendance of the recipient at the Annual Conference of the Society.
6. No formal nomination procedure is specified, but members of the Society may propose suitable candidates to the Nominations and Awards Committee through the Head Office of the Society (info@cscc-sccc.ca). Curriculum vitae and any other suitable documentation in support of the nominee must accompany nominations from the membership.
7. The Nominations and Awards Committee shall select one of the nominees for the Award for recommendation to the Council of the Society at its Fall Council meeting in the year before the Award is to be presented.
8. The President of the Society will notify the recipient of the award and inform the sponsor of the name of the recipient of the Award not later than March 1 in the year for which the Award is made.
9. The recipient of the Award is not usually expected to give an address or present a paper, but the Award and the reading of the citation shall usually be made at the Annual Conference of the Society.  A representative of the sponsor shall be invited to participate in the presentation.
10. The amendment of these Terms of Reference is the responsibility of the Council of the Society, subject to the concurrence of the sponsor of the Award.  Council of the Society and the corporate sponsor of the Award should review these Terms of Reference a minimum of once every five (5) years.

Dr. Anna Füzéry is the recipient of the 2026 CSCC Award for Education Excellence. This award is presented to an individual or group as a mark of recognition of outstanding contribution to education in the field of clinical chemistry.

Dr. Füzéry is currently the North Sector Point of Care Testing Medical Lead at Alberta Precision Laboratories and also Associate Clinical Professor in the Department of Laboratory Medicine and Pathology, University of Alberta, where she serves as Co-Director of the Clinical Biochemistry Postdoctoral Fellowship Program.

After she completed her fellowship training at Johns Hopkins University, Dr. Füzéry joined Alberta Health Services / Alberta Precision Laboratories in 2013 as a clinical biochemist supporting tertiary care and suburban hospitals and specialized in point of care testing (POCT) within Edmonton and North zones. Since then, she also gained formal professional certification in POCT, and is a recognized leader in the development, implementation, and delivery of POCT programs.

As an educator and mentor, Dr. Füzéry has inspired and supported countless students, trainees, and peers. As a co-director of the Clinical Biochemistry Fellowship program since 2015, she has shaped the next generation of laboratory professionals with skill, patience, and dedication. She strengthened the program by tirelessly supporting trainees with tools to achieve excellence including for pathophysiology learning resources, supplemental exposures, and additional rotations to fine tune the curriculum based on their personal preference. Fellows and residents in General Pathology consistently describe her guidance as transformative, providing not only technical expertise but also the values of professionalism, integrity, and lifelong learning. At the undergraduate level, she supervised numerous students in the medical laboratory science program with their fourth-year research project

Through her dedicated service to the profession, Dr. Füzéry has made an immeasurable impact on continuing education and the advancement of knowledge in laboratory medicine. She has provided leadership at the provincial, national, and international levels, chairing and contributing to numerous committees. Notable examples include serving as Chair of the Association for Diagnostics & Laboratory Medicine (ADLM) Rocky Mountain Section, Co-Chair of the CSCC Annual Conference, Head of the Education and Scientific Division of the CSCC Council, member of the ADLM Annual Meeting Organizing Committee, member of the CPSA Advisory Committee, Corresponding Member for the IFCC Mobile Health and Bioengineering in Laboratory Medicine group, and member of the CLSI Expert Panel on Point-of-Care Testing.  Many of these activities have lasting educational impact throughout the CSCC and on the field of clinical chemistry.

1. Nominations for this Award shall be solicited annually in the Newsletter, website, and email of the Society.
2. The deadline for nominations is October 31, in the year before the Award is to be presented.
3. The Award shall be presented to an individual or group as a mark of recognition of outstanding contribution to education in the field of clinical chemistry.
4. The Award shall usually be presented annually, but if in the opinion of the Awards Committee no suitable candidate is available in any year, the Award shall not be made.
5. The Award shall be accompanied by a framed certificate and an honorarium in the amount of $1,500. The balance remaining after the honorarium shall be used to meet the administrative expenses, the production of the framed certificate, and to make a contribution towards the expenses involved in ensuring the attendance of the recipient at the Annual Conference of the Society.
6. No formal nominations procedure is specified, but Members of the Society may propose suitable candidates to the Nominations and Awards Committee through the Head Office of the Society (info@cscc-sccc.ca). Curriculum vitae and any other suitable documentation in support of the nominee must accompany nominations from the membership.
7. The Nominations and Awards Committee shall select one of the nominees for the Award for recommendation to the Council of the Society at its Fall Council meeting in the year before the Award is to be presented.
8. The President of the Society will notify the recipient of the award and inform the sponsor of the name of the recipient of the Award not later than March 1 in the year for which the Award is made.
9. The recipient of the Award is not usually expected to give an address or present a paper, but the Award and the reading of the citation shall usually be made at the Annual Conference of the Society. A representative of the sponsor shall be invited to participate in the presentation.
10. The amendment of these Terms of Reference is the responsibility of the Council, subject to the concurrence of the sponsor of the Award.  The CSCC Council and the corporate sponsor of the Award should review these Terms of Reference a minimum of once every five (5)years.

Terms of Reference

1. Applications for these grants shall be solicited annually in the Newsletter, website, and email of the Society.
2. Short-term visits (i.e. elective visits) to other laboratories provides trainees in laboratory medicine with a unique opportunity to augment their skill sets. This can include learning a new technique and seeing how another laboratory works. Such visits also provide opportunities to form novel collaborative relationships with current and future colleagues. CSCC provides a limited number of Trainee Elective Visit Grants of up to $2,000 per grant each year in support of this important facet of laboratory medicine training.
3. The grants shall be presented annually. If in the opinion of the Nominations and Awards Committee there are no suitable individuals available in any year, these grants shall not be made.
4. Trainees are encouraged to apply for these grants if they meet all the following criteria:
   i. Applicants must be members of the CSCC.
   ii. Applicants must be enrolled EITHER in a CACB-accredited clinical biochemistry training program OR in a Royal College of Physicians and Surgeons of Canada-accredited medical biochemistry training program.
5. The Host Laboratory must perform clinical service in biochemistry, hematology, microbiology, immunology, genetics, and/or a related area.
6. The Host Laboratory must be located outside of the home city of the applicant’s training program.
7. Funds must be used within one year of being awarded or before completion of the training program, whichever is earlier.
8. Successful applicants must submit a summary article of their visit to CSCC News before completion of their training program. The article should describe goals that were achieved during the visit and how applicants plan to apply their new knowledge in the future. Applicants should coordinate the length and timing of their articles with the Editor in Chief of the publication.
9. The applicant is to submit an online application via the CSCC website. The application deadline is April 10 of each year, but this may be extended by decision of the Nominations and Awards Committee if no applications have been received by the deadline.
10. CSCC Head Office will forward all applications to the Head of CSCC Professional Affairs Division (PAD) who will then appoint up to three (3) reviewers per application. All reviewers are required to be CSCC members; one should be the Head of the Education and Scientific Affairs Division (ESAD), and one should be a CSCC Councillor if there is no conflict of interest. In awarding the grants, preference will be given to applicants who will be in their final year of study during the proposed visit and/or have not previously received a CSCC Trainee Elective Visit Grant. Whenever possible, grants will be distributed across two or more training programs each year. The reviewers complete scoring sheets and submit them to Head Office.
11. Head Office (info@cscc-sccc.ca) will notify applicants of the reviewer panel’s decision within one (1) month of the panel receiving applications.
12. The Head of the Professional Affairs Division (Council liaison to the Nominations and Awards Committee) will notify Council of the Committee’s decision(s) at the next Council meeting.
13. Grant recipients must provide a full accounting of expenses not more than 60 days following completion of the funded activity.
14. The amendment of these Terms of Reference is the responsibility of the Council and should be reviewed at least every five (5) years.

Application Form

Download PDF

Terms of Reference

1. Applications for this grant shall be solicited annually in the Newsletter, website, and email of the Society.

2. The grant shall be presented to a Full member of the CSCC to support leadership and/or administrative contributions in the field of Clinical Chemistry or Pathology and Laboratory Medicine. This award is intended to encourage and support the administrative and leadership role of members including (but not limited to):
a) administrative positions in hospitals, universities, private laboratories, government and industry,
b) participation in committees of Provincial, National and International professional and regulatory agencies,
c) leadership role in the strategic planning and implementation of laboratory services.

3. The applicant is to submit an online application via the CSCC website. The applicant is to submit with their application a statement explaining why this grant is required, and a proposed budget. If their employer provides funds for education and travel, the candidates shall explain why these funds cannot be used for the purpose requested.

4. The deadline for applications is November 30 each year. Preference is to award the grant for an activity occurring in the award year that has not yet occurred. Exceptions may be considered with the approval of Council.

5. The Nominations and Awards Committee shall select the recipient of the grant.

6. The grant shall usually be presented annually, but if in the opinion of the Nominations and Awards Committee no suitable candidate(s) is available in any year, the grant shall not be made. A maximum of three grants shall be given in any fiscal year. If the grant has not been awarded, the grant may remain open for the remainder of the award year.

7. Awarding of this grant is subject to available funds from the Grant amounts may be reduced, or the grant may not be funded in any given year at the discretion of the Council.

8. Recipients of the Grant shall receive a maximum of $3,000, sponsored by CSCC Council.

9. The Executive Director of the Society will notify the recipient not later than one (1) month of the decision by the Nominations and Awards Committee.

10. The Head of the Professional Affairs Division (Council liaison to the Nominations and Awards Committee) shall report the Committee’s choice at the next CSCC Council meeting. The grant will also be announced at the Annual General Meeting of the Society.

11. The recipient of the grant must submit a summary article of their learning to CSCC News in the same calendar year the grant is allocated, coordinating the length and timing of the article with the Editor in Chief of the publication.

12. Grant recipients must provide a full accounting of expenses not more than sixty (60) days following completion of the funded activity.

13. The amendment of these Terms of Reference is the responsibility of the Council and should be reviewed at least every five (5) years.

CSCC Grant for Leadership Application Form

Download Trainee Grant TOR

1. Application for these grants shall be solicited annually in the call out for Abstracts.
2. Participation in the Annual Conference of the CSCC provides trainees in laboratory medicine with a valuable opportunity to increase their knowledge in laboratory medicine and related fields, to discuss their work with colleagues, and to establish novel collaborative relationships. CSCC provides a limited number of Trainee Travel Grants each year in support of this important facet of laboratory medicine training.
3. The grants shall be presented annually. If in the opinion of the Nominations and Awards Committee there are no suitable individuals available in any year, these grants shall not be made.
4. CSCC Council shall determine the annual budget for the amount to be given for the grants in any given year.
5. Trainees are encouraged to apply for these grants if they meet all the following criteria:
   -They are members of CSCC.
   -They are enrolled EITHER in a CACB-accredited clinical biochemistry training program OR in a Royal College of Physicians and Surgeons of Canada-accredited medical biochemistry training program.
   -They are presenting work at the conference that they performed in their current training program.
6. The application process for this grant is part of the abstract submission process for the CSCC Annual Meeting. Eligible trainees should indicate in the relevant place on their abstract submission form that they wish to be considered for a CSCC Trainee Travel Grant. CSCC Head Office will contact applicants if additional information is required.
7. In awarding the travel grants, the following are considered:
   Preference will be given to trainees
   -in their final year of study
   -who have not previously received a CSCC Trainee Travel Grant
   -who reside outside of the city where the conference is being held.
   Abstracts will be evaluated based on the amount of work involved in the study and the applicability of the results to the practice of clinical/medical biochemistry. Preference will be given to clinical and analytical abstracts, followed by basic research.
   Whenever possible, grants will be distributed across two or more training programs.
8. The initial top ten is reviewed by CSCC Head Office and the CSCC Treasurer in accordance with the criteria. If there are more than 10 applications, review by the CSCC Nominations and Awards Committee will be required in consultation with the CSCC Executive if additional funding is requested. The list of recipients of the Trainee Travel Grants will be presented to the Council of the Society at its next meeting by the Head of the Professional Affairs Division (PAD), who is Council liaison to the Nominations and Awards Committee.
9. Applicants will be notified by CSCC Head Office of the Nomination and Awards Committee’s decision as soon as all received travel grant applications have been reviewed, which should be not later than two (2) months before the Annual Meeting of the Society in the year for which the grants are given.
10. Grant recipients must provide a full accounting of expenses to CSCC Head Office (info@cscc-sccc.ca) not more than 60 days following completion of the funded activity.
11. The amendment of these Terms of Reference is the responsibility of the CSCC Council. The CSCC Council should review these Terms of Reference at least once every five (5) years.

CSCC Grant for Educational Activities and Professional Development

1. Applications for this grant shall be solicited annually in the Newsletter, website, and email of the Society.
2. The grant shall be presented to a Full member of the CSCC to support their educational activities and/or development of the profession in the field of Clinical Chemistry or Pathology and Laboratory Medicine. The grant is intended to encourage and support members who require additional funding, beyond that provided by their employer, to attend national/international conferences, take additional courses, or participate in other educational activities and professional development including (but not limited to):
   a. Attendance at the CSCC annual meeting or another national or international meeting relevant to laboratory medicine
   b. Visiting other laboratories to obtain specialized expertise in areas of laboratory medicine
   c. Attendance at provincial, national, or international courses, workshops, task forces or committees that promote professional development in laboratory medicine.
3. This grant is not intended to cover examination fees or related expenses
4. The applicant is to submit an online application via the CSCC website. The applicant is to submit with their application a statement explaining why this grant is required, and a proposed budget. If their employer provides funds for education and travel, the applicant shall explain why these funds cannot be used for the purpose requested.
5. The deadline for applications is November 30 each year. Preference is to award the grant for an activity occurring in the award year that has not yet occurred. Exceptions may be considered with the approval of Council.
6. The Nominations and Awards Committee shall choose the recipient of the grant.
7. The grant shall usually be presented annually, but, if in the opinion of the Nominations and Awards Committee, no suitable candidate is available, the grant shall not be made. A maximum of three awards shall be given in any fiscal year. If the grant has not been awarded, the grant may remain open for the remainder of the award year.
8. Awarding of this grant is subject to available funds from the Grant amounts may be reduced, or the grant may not be funded in any given year at the discretion of the Council.
9. Recipients of the grant shall receive a maximum of $3000, sponsored by the CSCC Council. The Head of the Professional Affairs Division (Council liaison to the Nominations and Awards Committee) shall report the Committee’s choice to the CSCC Council at the next Council meeting.
10. The Executive Director of the Society will notify the recipient of the grant not later than one (1) month of the decision by the Nominations and Awards Committee.
11. The recipient of the grant must submit a summary article of their learning to CSCC News in the same calendar year the grant is allocated, coordinating the length and timing of the article with the Editor in Chief of the publication.
12. Grant recipients must provide a full accounting of expenses not more than sixty (60)days following completion of the funded activity.
13. The amendment of the Terms of Reference is the responsibility of the Council. The terms of reference should be reviewed every five (5) years.

CSCC Grant for Education Application Form

CSCC PROVINCIAL EDUCATION GRANTS TOR

PROVINCIAL EDUCATION GRANTS Purpose

The purpose of Provincial Education Grants is to assist provincial societies with the provision of educational activities for their members. To further this goal, funding is allocated in advance to each provincial section so that they can plan events with the assurance that funds will be available. Funds will only be disbursed following the actual event. Amount of Grant: up to a maximum of $1,000 payable upon receipt of invoices

PROCEDURE

1. Application for the grant is to be made to emailed by an executive member of the provincial society to CSCC Head Office (info@cscc-sccc.ca) with supporting documentation of the event in the form of copies of the program and a proposed budget.
2. CSCC Head Office will forward the application to the Head of the Education and Scientific Affairs Division (ESAD) for review and approval.
3. Request for reimbursement must be received at CSCC Head Office by November 30 of the year in which the event occurred.
4. If a host does not have the ability to fund an event, application for an advance may be made to the Head of ESAD. At the discretion of the Head and the Treasurer, funds can be advanced on the understanding that documentation of how the funds were used will be provided after the event takes place.

Approved June 2015

CSCC REGIONAL GRANT APPLICATION FORM